14-hydroxyclarithromycin

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-12,13-dihydroxy-14-(1-hydroxyethyl)-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

BLPFDXNVUDZBII-KNPZYKNQSA-N CHEBI:189888 0 Reactome links 4 studies

4 Observed studies

4 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: BLPFDXNVUDZBII-KNPZYKNQSA-N
InChI Key: BLPFDXNVUDZBII-KNPZYKNQSA-N
IUPAC name: (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-12,13-dihydroxy-14-(1-hydroxyethyl)-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
Preferred name: 14-hydroxyclarithromycin
INN name: —
Synonym: —
ChEBI: CHEBI:189888

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles